Gangliosides as immunomodulators

Advances in Experimental Medicine and Biology

Volumn 601, Issue , 2007, Pages 195-203

  Potapenko, Miroslava ^a   Shurin, Galina V ^a   De León, Joel ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; GANGLIOSIDE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ANTIGEN PRESENTING CELL; BIOLOGICAL MODEL; CELL LINE; CHEMICAL MODEL; CHEMISTRY; DISEASE COURSE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; BIOLOGICAL RESPONSE MODIFIERS; CELL LINE, TRANSFORMED; DISEASE PROGRESSION; GANGLIOSIDES; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NEOPLASMS; T-LYMPHOCYTES;

EID: 34848833988     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72005-0_20     Document Type: Conference Paper

References (55)

1. Angata, T. and Varki, A. (2002) Chemical diversity in the sialic acids and related alpha-keto acids: An evolutionary perspective. Chem. Rev. 102, 439-469.
2. Bennaceur, K., Popa, I., Portoukalian, J., Berthier-Vergnes, O. and Peguet-Navarro, J. (2006) Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis. Int. Immunol. 18, 879-886.
3. Bergelson, L.D. (1995) Serum gangliosides as endogenous immunomodulators. Immunol. Today 16, 483-486.
4. Boon, T., Coulie, P.G. and Van Den Eynde, B. (1997) Tumor antigens recognized by T cells. Immunol. Today 18, 267-268.
5. Bronnum, H., Seested, T., Hellgren, L.I., Brix, S. and Frokiaer, H. (2005) Milk-derived GM(3) and GD(3) differentially inhibit dendritic cell maturation and effector functionalities. Scand. J. Immunol. 61, 551-557.
6. Caldwell, S., Heitger, A., Shen, W., Liu, Y., Taylor, B. and Ladisch, S. (2003) Mechanisms of ganglioside inhibition of APC function. J. Immunol. 171, 1676-1683.
7. Cheresh, D.A., Pierschbacher, M.D., Herzig, M.A. and Mujoo, K. (1986) Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102, 688-696.
8. Colell, A., Garcia-Ruiz, C., Roman, J., Ballesta, A. and Fernandez-Checa, J.C. (2001) Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-kappa B-dependent survival pathway. FASEB J. 15, 1068-1070.
9. Crespo, F.A., Sun, X., Cripps, J.G. and Fernandez-Botran, R. (2006) The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses. J. Leukoc. Biol. 79, 586-595.
10. De Leon, J., Fernandez, A., Mesa, C., Clavel, M. and Fernandez, L.E. (2006) Role of tumourassociated N-glycolylated variant of GM3 ganglioside in cancer progression: Effect over CD4 expression on T cells. Cancer Immunol. Immunother. 55, 443-450.
11. De Maria, R., Lenti, L., Malisan, F., d'Agostino, F., Tomassini, B., Zeuner, A., Rippo, M.R. and Testi, R. (1997) Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 277, 1652-1655.
12. Deng, W., Li, R. and Ladisch, S. (2000) Influence of cellular ganglioside depletion on tumor formation. J. Natl. Cancer Inst. 92, 912-917.
13. Diatlovitskaia, E.V., Kliuchareva, E.V., Matveeva, V.A., Sinitsyna, E.V. and Akhmed-Zade, A.S. (1985) Effect of gangliosides on the cytotoxic activity of natural killers from Syrian hamsters. Biochemistry (Russia) 50, 1514-1516.
14. Feizi, T. (1985) Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314, 53-57.
15. Finke, J.H., Rayman, P., George, R., Tannenbaum, C.S., Kolenko, V., Uzzo, R., Novick, A.C. and Bukowski, R.M. (2001) Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: Role of nuclear factor-kappaB suppression. Clin. Cancer Res. 7, 940s-946s.
16. Fujitani, M., Kawai, H., Proia, R.L., Kashiwagi, A., Yasuda, H. and Yamashita, T. (2005) Binding of soluble myelin-associated glycoprotein to specific gangliosides induces the association of p75NTR to lipid rafts and signal transduction. J. Neurochem. 94, 15-21.
17. Gonwa, T.A., Westrick, M.A. and Macher, B.A. (1984) Inhibition of mitogen- and antigeninduced lymphocyte activation by human leukemia cell gangliosides. Cancer Res. 44, 3467-3470.
18. Gottschalk, A. (1955) Structural relation between sialic acid, neuraminic acid, and 2-carboxypyrrole. Nature 176, 881-882.
19. Hakomori, S. (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Ann. Rev. Biochem. 50, 733-764.
20. Hakomori, S. and Kannagi, R. (1983) Glycosphingolipids as tumor-associated and differentiation markers. J. Natl. Cancer Inst. 71, 231-251.
21. Hettmer, S., Ladisch, S. and Kaucic, K. (2005) Low complex ganglioside expression characterizes human neuroblastoma cell lines. Cancer Lett. 225, 141-149.
22. Hoon, D.S., Okun, E., Neuwirth, H., Morton, D.L. and Irie, R.F. (1993) Aberrant expression of gangliosides in human renal cell carcinomas. J. Urol. 150, 2013-2018.
23. Iber, H., Zacharias, C. and Sandhoff, K. (1992) The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golgi by the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. Glycobiology 2, 137-142.
24. Keenan, T.W., Morre, D.J. and Basu, S. (1974) Ganglioside biosynthesis. Concentration of glycosphingolipid glycosyltransferases in Golgi apparatus from rat liver. J. Biol. Chem. 249, 310-315.
25. Klenk (1941) Uber die ganglioside, eine neue gruppe von zukerhaltigen gehirnlipoiden. Z. Physiol. Chem. 273, 76.
26. Klenk (1942) Neuraminsaure, das spaltprodukt eines neuen gehirnlipoids. Z. Physiol. Chem. 268, 50.
27. Ladisch, S., Becker, H. and Ulsh, L. (1992) Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochimica et Biophysica Acta 1125, 180-188.
28. Ladisch, S., Gillard, B., Wong, C. and Ulsh, L. (1983) Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43, 3808-3813.
29. Ladisch, S., Hasegawa, A., Li, R. and Kiso, M. (1995) Immunosuppressive activity of chemically synthesized gangliosides. Biochemistry. 34, 1197-1202.
30. Ladisch, S., Kitada, S. and Hays, E.F. (1987) Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Invest. 79, 1879-1882.
31. Ladisch, S., Li, R. and Olson, E. (1994) Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. U.S.A. 91, 1974-1978.
32. Ladisch, S., Ulsh, L., Gillard, B. and Wong, C. (1984) Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. J. Clin. Invest. 74, 2074-2081.
33. Ladisch, S., Wu, Z.L., Feig, S., Ulsh, L., Schwartz, E., Floutsis, G., Wiley, F., Lenarsky, C. and Seeger, R. (1987) Shedding of GD2 ganglioside by human neuroblastoma. Int. J. Cancer 39, 73-76.
34. Ledeen, R.W. and Yu, R.K. (1982) Gangliosides: Structure, isolation, and analysis. Meth. Enzymol. 83, 139-191.
35. Lengle, E.E., Krishnaraj, R. and Kemp, R.G. (1979) Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids. Cancer Res. 39, 817-822.
36. Li, R.X. and Ladisch, S. (1991) Shedding of human neuroblastoma gangliosides. Biochim. Biophys. Acta 1083, 57-64.
37. Mandon, E.C., Ehses, I., Rother, J., van Echten, G. and Sandhoff, K. (1992) Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J. Biol. Chem. 267, 11144-11148.
38. Merritt, W.D., Bailey, J.M. and Pluznik, D.H. (1984) Inhibition of interleukin-2-dependent cytotoxic T lymphocyte growth by gangliosides. Cell. Immunol. 89, 1-10.
39. Offner, H., Thieme, T. and Vandenbark, A.A. (1987) Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139, 3295-3305.
40. Partington, C.R. and Daly, J.W. (1979) Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes. Mol. Pharmacol. 15, 484-491.
41. Pizzo, P. and Viola, A. (2003) Lymphocyte lipid rafts: Structure and function. Curr. Opin. Immunol. 15, 255-260.
42. Portoukalian, J., David, M.J., Shen, X., Richard, M. and Dubreuil, C. (1989) Tumor sizedependent elevations of serum gangliosides in patients with head and neck carcinomas. Biochem. Int. 18, 759-765.
43. Ritter, G. and Livingston, P.O. (1991) Ganglioside antigens expressed by human cancer cells. Semin. Cancer Biol. 2, 401-409.
44. Senn, H.J., Orth, M., Fitzke, E., Wieland, H. and Gerok, W. (1989) Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem .181, 657-662.
45. Shurin, G.V., Shurin, M.R., Bykovskaia, S., Shogan, J., Lotze, M.T. and Barksdale, E.M., Jr. (2001) Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61, 363-369.
46. Somova, O.G., Tekieva, E.A., Diatlovitskaia, E.V., Bassalyk, L.S. and Bergel'son, L.D. (1991) Ganglioside (GD3) in serum of cancer patients. Vopr. Med. Khim. (Russia) 37, 21-23.
47. Sorice, M., Parolini, I., Sansolini, T., Garofalo, T., Dolo, V., Sargiacomo, M., Tai, T., Peschle, C., Torrisi, M.R. and Pavan, A. (1997) Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid Res. 38, 969-980.
48. Sorice, M., Pavan, A., Misasi, R., Sansolini, T., Garofalo, T., Lenti, L., Pontieri, G.M., Frati, L. and Torrisi, M.R. (1995) Monosialoganglioside GM3 induces CD4 internalization in human peripheral blood T lymphocytes. Scand. J. Immunol. 41, 148-156.
49. Steck, T.L. and Dawson, G. (1974) Topographical distribution of complex carbohydrates in the erythrocyte membrane. J. Biol. Chem. 249, 2135-2142.
50. Svennerholm, L. (1980) Gangliosides and synaptic transmission. Adv. Exp. Med. Biol. 125, 533-544.
51. Thornton, M.V., Kudo, D., Rayman, P., Horton, C., Molto, L., Cathcart, M.K., Ng, C., Paszkiewicz-Kozik, E., Bukowski, R., Derweesh, I., Tannenbaum, C.S. and Finke, J.H. (2004) Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas. J. Immunol. 172, 3480-3490.
52. Tourkova, I.L., Shurin, G.V., Chatta, G.S., Perez, L., Finke, J., Whiteside, T.L., Ferrone, S. and Shurin, M.R. (2005) Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J. Immunol. 175, 3045-3052.
53. Wang, R.F., Zeng, G., Johnston, S.F., Voo, K. and Ying, H. (2002) T cell-mediated immune responses in melanoma: Implications for immunotherapy. Crit. Rev. Oncol. Hematol. 43, 1-11.
54. Yogeeswaran, G. and Hakomori, S. (1975) Cell contact-dependent ganglioside changes in mouse 3T3 fibroblasts and a suppressed sialidase activity on cell contact. Biochemistry 14, 2151-2156.
55. Yu, R.K. and Ledeen, R. (1969) Configuration of the ketosidic bond of sialic acid. J. Biol. Chem. 244, 1306-1313.